Dare Bioscience, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2013 | — | $-94.3M | $5.5M |
| FY2014 | — | $45.3M | $51.2M |
| FY2015 | — | $-46.9K | $219.4K |
| FY2016 | — | $-710.6K | $44.6K |
| FY2017 | — | $13.3M | $7.6M |
| FY2018 | — | $6.7M | $6.8M |
| FY2019 | — | $440.8K | $4.8M |
| FY2020 | — | $-1.2M | $4.7M |
| FY2021 | — | $38.8M | $51.7M |
| FY2022 | — | $11.1M | $34.7M |